stars 1 stars 2 stars 3

Established in 1978, Codal Synto supplies the generic pharmaceutical market with well established, therapeutically equivalent, branded products. We are located in Limassol, on the southern shores of Cyprus, and have an extensive international network of associates and partners. We are committed to providing safe, affordable and high quality pharmaceuticals, supported by a very lean yet efficient operation. This, combined with our flat managerial structure, allows us to be both highly competitive in our prices and quick in taking decisions, a critical advantage when trying to capitalize on new market opportunities. We hold a large number of high quality product dossiers which conform to stringent European standards and form the basis of our significant intellectual property. We maintain a close relationship with Medochemie, a branded generic manufacturer on a global scale, withwhich we have a long term contract manufacturing agreement to complement our own in-house capabilities. This relationship also provides Codal Synto with unparalleled access to global markets.

Codal-Synto Ltd Questions

The Codal-Synto Ltd annual revenue was $3 million in 2026.

The NAICS codes for Codal-Synto Ltd are [32541, 325, 3254, 32].

The SIC codes for Codal-Synto Ltd are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users